BR112014024491A2 - proteínas da membrana externa de histophilus somni e métodos das mesmas - Google Patents

proteínas da membrana externa de histophilus somni e métodos das mesmas

Info

Publication number
BR112014024491A2
BR112014024491A2 BR112014024491A BR112014024491A BR112014024491A2 BR 112014024491 A2 BR112014024491 A2 BR 112014024491A2 BR 112014024491 A BR112014024491 A BR 112014024491A BR 112014024491 A BR112014024491 A BR 112014024491A BR 112014024491 A2 BR112014024491 A2 BR 112014024491A2
Authority
BR
Brazil
Prior art keywords
methods
outer membrane
membrane proteins
histophilus somni
somni
Prior art date
Application number
BR112014024491A
Other languages
English (en)
Inventor
Dean Lilly Brice
P Knittel Jeffrey
Original Assignee
Boehringer Ingelheim Vetmedica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Inc filed Critical Boehringer Ingelheim Vetmedica Inc
Publication of BR112014024491A2 publication Critical patent/BR112014024491A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)

Abstract

resumo patente de invenção: "proteínas da membrana externa de histophilus somni e métodos das mesmas". a presente invenção refere-se a composições imunológicas de proteínas da membrana externa (omps) de h. somni, bem como a métodos de extração, a um modelo de estímulo respiratório, a métodos de administração e a kits e testes de diagnóstico.
BR112014024491A 2012-04-05 2013-04-02 proteínas da membrana externa de histophilus somni e métodos das mesmas BR112014024491A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261620652P 2012-04-05 2012-04-05
US13/796,653 US9597386B2 (en) 2012-04-05 2013-03-12 Outer membrane proteins of Histophilus somni and methods thereof
PCT/US2013/034918 WO2013151979A1 (en) 2012-04-05 2013-04-02 Outer membrane proteins of histophilus somni and methods thereof

Publications (1)

Publication Number Publication Date
BR112014024491A2 true BR112014024491A2 (pt) 2017-08-08

Family

ID=49292471

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014024491A BR112014024491A2 (pt) 2012-04-05 2013-04-02 proteínas da membrana externa de histophilus somni e métodos das mesmas

Country Status (17)

Country Link
US (1) US9597386B2 (pt)
EP (1) EP2833912A1 (pt)
JP (1) JP2015519305A (pt)
KR (1) KR20150003269A (pt)
CN (1) CN104470539A (pt)
AR (2) AR090613A1 (pt)
AU (1) AU2013243622A1 (pt)
BR (1) BR112014024491A2 (pt)
CA (1) CA2866888A1 (pt)
CL (1) CL2014002658A1 (pt)
CO (1) CO7160028A2 (pt)
EA (1) EA201401078A1 (pt)
MX (1) MX2014012013A (pt)
PH (1) PH12014502223A1 (pt)
SG (1) SG11201406209WA (pt)
UY (1) UY34733A (pt)
WO (1) WO2013151979A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2809283A1 (en) * 2011-11-10 2013-05-10 Dokdo Co., Ltd. Heating container
US9597386B2 (en) 2012-04-05 2017-03-21 Boehringer Ingelheim Vetmedica, Inc. Outer membrane proteins of Histophilus somni and methods thereof
KR102304838B1 (ko) * 2014-02-07 2021-09-28 바스프 에스이 개선된 바이오매스 분리 거동을 갖는 변형된 미생물
HUE059284T2 (hu) * 2014-03-25 2022-11-28 Boehringer Ingelheim Animal Health Usa Inc Attenuált histophilus somni-t tartalmazó immunológiai készítmények
KR101960017B1 (ko) * 2018-04-09 2019-07-15 전북대학교 산학협력단 호흡기 질병의 원인체를 검출하기 위한 조성물 및 이를 이용한 방법
KR101960016B1 (ko) * 2018-04-09 2019-07-15 전북대학교 산학협력단 호흡기 질병의 원인체를 검출하기 위한 조성물 및 이를 이용한 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
JPS60500673A (ja) 1983-03-08 1985-05-09 コモンウエルス　セラム　ラボラトリ−ズ　コミツシヨン 抗原活性を有するアミノ酸配列
US6100066A (en) 1992-04-09 2000-08-08 University Of Saskatchewan Nucleic acid molecules encoding Haemophilus somnus proteins
AU3883893A (en) 1992-04-09 1993-11-18 University Of Saskatchewan (Haemophilus somnus) immunogenic proteins
US5534256A (en) 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
AU6160599A (en) 1998-09-25 2000-04-17 Regents Of The University Of California, The Vaccine based on attenuated (haemophilus somnus)
JP2004222593A (ja) * 2003-01-23 2004-08-12 National Agriculture & Bio-Oriented Research Organization 反芻獣病原細菌の主要外膜タンパク質をコードする遺伝子
US9597386B2 (en) 2012-04-05 2017-03-21 Boehringer Ingelheim Vetmedica, Inc. Outer membrane proteins of Histophilus somni and methods thereof

Also Published As

Publication number Publication date
AR090613A1 (es) 2014-11-26
EP2833912A1 (en) 2015-02-11
UY34733A (es) 2013-10-31
EA201401078A1 (ru) 2015-04-30
AU2013243622A1 (en) 2014-09-25
SG11201406209WA (en) 2014-10-30
AR090624A1 (es) 2014-11-26
US9597386B2 (en) 2017-03-21
WO2013151979A1 (en) 2013-10-10
CN104470539A (zh) 2015-03-25
JP2015519305A (ja) 2015-07-09
PH12014502223A1 (en) 2015-01-12
MX2014012013A (es) 2014-11-25
KR20150003269A (ko) 2015-01-08
CA2866888A1 (en) 2013-10-10
US20130266613A1 (en) 2013-10-10
CO7160028A2 (es) 2015-01-15
CL2014002658A1 (es) 2015-03-20

Similar Documents

Publication Publication Date Title
BR112014024491A2 (pt) proteínas da membrana externa de histophilus somni e métodos das mesmas
BR112015014462A2 (pt) vetorização farmacêutica de uma via de sinalização de dinucleotídeos cíclicos de mamíferos
BR112015019066A2 (pt) Anticorpos humanos para proteína f do vírus respiratório sincicial e métodos de uso dos mesmos
EA201691060A1 (ru) Терапия транстиретинового (ттр) амилоидоза антителами, а также антитела, полученные от человека для указанной терапии
BR112013029834A2 (pt) vacinas individualizadas para câncer
BR112013022397A2 (pt) vacinas combinadas com doses menores de antígeno e/ou adjuvante
BR112014001875A2 (pt) sistema e método personalizáveis para anestesiar membrana timpânica
BR112016012129A8 (pt) métodos para produção, expansão e purificação de células epiteliais do pigmento da retina, composição farmacêutica e uso das células
BR112015022936A2 (pt) vesículas de colestossoma para a incorporação de moléculas em quilomícrons
EA201490258A1 (ru) Составы парентеральной норовирусной вакцины
BR112014013786A8 (pt) método para ventilação de um indivíduo, método para rapidamente ventilar um indivíduo que apresenta desconforto respiratório, e, dispositivo para ventilação de um indivíduo através de uma ou mais passagens do corpo
BR112013026661A2 (pt) método de entrega de vacina
BR112014031386A2 (pt) vacinas para meningococos do sorogrupo x
BR112015012711A2 (pt) método de produção de uma vacina de mycoplasma
BR112015014174A2 (pt) composição de vacina para indivíduos virgens
BR112014030800A2 (pt) clipe cirúrgico com mola interior
BR112017022755A2 (pt) formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual
BR112013029417A2 (pt) composições de vacina de matriz proteica incluindo policátions
WO2015076717A3 (en) Mscs in the treatment of cardiac disorders
CL2015003563A1 (es) Marcador para trastornos de la esfingomielinasa ácida y sus usos.
BR112013031431A2 (pt) método para o diagnóstico da doença de gaucher
BR112015005285A2 (pt) enxaguantes bucais e composições de tratamento da sensibilidade dentária
BR112015028252A2 (pt) método de tratamento de câncer de pulmão por vacinação com lipopeptídeo muc-1
BR112014016423A8 (pt) composição de controle de doença de planta
SMT201600334B (it) Interferone beta per l'uso nel trattamento della malattia del tratto respiratorio inferiore causata da influenza

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)